Related Experiment Video
Updated: Apr 1, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Understanding, Avoiding, and Managing Severe Filler Complications
Berthold Rzany1, Claudio DeLorenzi
1Berlin, Germany; and Kitchener, Ontario, Canada From RZANY & HUND and the DeLorenzi Clinic.
Injectable fillers can cause adverse events, but severe reactions are rare. Poor aesthetic outcomes are more common and preventable with proper training and adherence to best practices for filler injections.
Area of Science:
- Dermatology
- Aesthetic Medicine
- Plastic Surgery
Background:
- Injectable fillers are widely used for aesthetic enhancement.
- Adverse events associated with fillers range from mild to severe.
- Severe adverse events, though uncommon, pose challenges in risk factor identification and treatment.
Purpose of the Study:
- To review the spectrum of adverse events associated with injectable fillers.
- To differentiate the frequency and impact of severe adverse events versus poor aesthetic outcomes.
- To emphasize strategies for preventing common, yet avoidable, negative outcomes.
Main Methods:
- Literature review of adverse events reported for various injectable fillers.
- Analysis of the incidence and severity of different types of filler complications.
- Discussion of preventative measures and best practices in aesthetic procedures.
Main Results:
- While severe adverse events like nodules, abscesses, and vascular occlusion can occur, they are infrequent for most fillers.
- Poor aesthetic outcomes are significantly more common than severe adverse events.
- Preventable factors contribute to suboptimal aesthetic results.
Conclusions:
- Severe adverse events from fillers are rare but require careful consideration.
- Focusing on proper training and best practices can significantly reduce the incidence of poor aesthetic outcomes.
- Ensuring practitioner education is key to improving patient safety and satisfaction with injectable fillers.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

